We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > rare

News List

SpringWorks Therapeutics raises $125m for rare oncology programmes pharmaceutical-technology
April 03, 2019
US-based SpringWorks Therapeutics, which specialises on developing medicines and treatments for cancers and severe rare diseases, has raised $125m in a series B funding round led by Perceptive Advisors.
Canadians with rare lung disease are relieved to now have publicly funded access to potentially life-extending treatment firstwordpharma
December 02, 2018
At the end of a successful Pulmonary Hypertension Awareness Month, members of the Pulmonary Hypertension Association of Canada (PHA Canada) and Scleroderma Canada (SC) have come together to thank provincial governments for providing the majority of Canadi

Previous page 1 2 Next page